Treatment of growth hormone attenuates hepatic steatosis in hyperlipidemic mice via downregulation of hepatic CD36 expression

The recombinant human growth hormone (GH) has been used for the treatment of growth hormone deficiency (GHD) and diverse short stature state, and its physiological and therapeutic effects are well documented. However, since the effect of GH treatment on metabolic disorders has not been well characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Hyung Seok, Kim, Kyeongdae, Lee, Mi-Ran, Kim, Shin-Hye, Choi, Jae-Hoon, Park, Mi Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651854/
https://www.ncbi.nlm.nih.gov/pubmed/33209195
http://dx.doi.org/10.1080/19768354.2020.1778080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651854/
https://www.ncbi.nlm.nih.gov/pubmed/33209195
http://dx.doi.org/10.1080/19768354.2020.1778080

Ejemplares similares